Activated prothrombin complex concentrate (FEIBA(®) ) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry

Ezio Zanon, Samantha Pasca, Cristina Santoro, Gabriella Gamba, Sergio M Siragusa, Angiola Rocino, Isabella Cantori, Augusto B Federici, Luciana Mameli, Gaetano Giuffrida, Anna Falanga, Corrado Lodigiani, Rita C Santoro, Marta Milan, Chiara Ambaglio, Mariasanta Napolitano, Maria G Mazzucconi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)853-855
Number of pages3
JournalBritish Journal of Haematology
Volume184
Issue number5
DOIs
Publication statusPublished - Mar 2019

Keywords

  • *bleeding disorders
  • *coagulation factors
  • *factor VIII
  • *haemophilia
  • Blood Coagulation Factors/*administration & dosage/adverse effects
  • Female
  • Hemophilia A/*drug therapy
  • Humans
  • Italy
  • Male
  • Prospective Studies
  • *Registries
  • Retrospective Studies

Cite this

Zanon, E., Pasca, S., Santoro, C., Gamba, G., Siragusa, S. M., Rocino, A., Cantori, I., Federici, A. B., Mameli, L., Giuffrida, G., Falanga, A., Lodigiani, C., Santoro, R. C., Milan, M., Ambaglio, C., Napolitano, M., & Mazzucconi, M. G. (2019). Activated prothrombin complex concentrate (FEIBA(®) ) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry. British Journal of Haematology, 184(5), 853-855. https://doi.org/10.1111/bjh.15175